# Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

> **NCT00421083** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 180 (—)

## Conditions studied

- Erectile Dysfunction
- Spinal Cord Injuries

## Interventions

- **DRUG:** tadalafil

## Key facts

- **NCT ID:** NCT00421083
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 180 (—)
- **Last updated:** 2007-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421083, "Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00421083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*